SCHEMBL19007315

SCHEMBL19007315

Cc1ccc(C)c(N(C)CCN(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 3/20 0.37
UTS2R Q9UKP6 2/20 0.36
TDP1 Q9NUW8 2/20 0.35
TAAR1 Q96RJ0 1/20 0.34
GAA P10253 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
TRPA1 O75762 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
PTPN11 Q06124 1/20 0.32
NOS1 P29475 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15872033 0.84 SMN1; SMN2 (0.46) HTTSMN1; SMN2CYP1A2CYP2D6CYP2C19
SCHEMBL18757121 0.84 HCAR3 (0.36) HTTSMN1; SMN2ALDH1A1TDP1TAAR1
SCHEMBL11054233 0.82 MAPT (0.38) HTTSMN1; SMN2ALDH1A1TDP1TAAR1
SCHEMBL23469288 0.79 ALDH1A1 (0.38) HTTSMN1; SMN2ALDH1A1GAALMNA
SCHEMBL10111220 0.79 ALDH1A1 (0.38) HTTSMN1; SMN2CYP1A2ALDH1A1TDP1
SCHEMBL17127897 0.78 ALDH1A1 (0.47) HTTSMN1; SMN2CYP1A2CYP2D6CYP2C19
SCHEMBL22607366 0.78 LMNA (0.44) HTTSMN1; SMN2ALDH1A1UTS2RLMNA
SCHEMBL7997975 0.78 ALDH1A1 (0.40) HTTSMN1; SMN2ALDH1A1GAALMNA
SCHEMBL763820 0.75 AR (0.41) SMN1; SMN2CYP2D6CYP2C19ALDH1A1TAAR1
SCHEMBL10104423 0.74 CRHR1 (0.37) HTTSMN1; SMN2CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174689-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174689-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL3 HTT 1155/4885SMN1; SMN2 2394/4885CYP1A2 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.